Home Newsfeeds HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

byBenzinga Newsdesk

January 17, 2023

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

What’s Happening With US Steel Shares On Monday?

By Shivani Kumaresan

June 17, 11:18 AM

U.S. Steel forecasts Q2 2024 adjusted net earnings per share of $0.76 to $0.80, under the consensus estimate of $0.83, amidst stable domestic demand but challenging market dynamics, as detailed by CEO David B. Burritt.

Bed Bath & Beyond CFO Gustavo Arnal Falls To Death From Jenga Building In NYC

By Shanthi Rexaline

September 4, 10:33 AM

Bed Bath & Beyond, Inc.’s (NYSE: BBBY) chief financial officer Gustavo Arnal has been identified as the person who jumped off the 18th floor of a Tribeca skyscraper, aka the Jenga Building, to his death on Friday, the New York Post reported.

BBBY